期刊文献+

NAG及其同工酶对儿童1型糖尿病肾病和视网膜病变早期诊断的意义 被引量:2

The Early Diagnostic Value of NAG and Isoforms Assay in Diabetic Nephropathy and Retinopathy of Children Type 1 Diabetes Mellitus
下载PDF
导出
摘要 目的研究儿童1型糖尿病肾脏病变和视网膜病变早期N-乙酰-β-D-氨基葡萄糖苷酶(N-acetyl-beta-D-glu-cosaminidase,NAG)及其同工酶的活性变化。方法利用日立7150型生化自动分析仪,采用速率法测定NAG及同工酶NAG A和NAG B的活性。检测68例儿童1型糖尿病患者和50例对照组儿童NAG及其同工酶的活性。儿童1型糖尿病患者按照有无视网膜病变进行分组,分析统计学差异。结果视网膜病变组血清NAG及其同工酶活性与无视网膜病变组无统计学差异(P>0.05),但是均明显高于对照组(P<0.001);视网膜病变组尿液NAG及同工酶活性高于无视网膜病变组,两组均高于对照组(P<0.001)。结论NAG及其同工酶在儿童1型糖尿病中可作为肾脏和视网膜早期病变的标志物。 Objective Study the changes of N-acetyl-beta-D-glucosaminidase(NAG) and isoforms at early stage of diabetic retinopathy and nephropathy in children type 1 diabetes mellitus.Methods 68 cases of children type 1 diabetes mellitus patients and 50 healthy controls were included in this study.All patients were divided into 2 groups according to retinopathy and non-retinopathy.Assay the activities of NAG and isoforms,and analyze the difference.Results Blood sample:Children with type 1 diabetes mellitus had a significantly higher level of NAG and isoforms than controls(P<0.001),and no difference in retinopathy group and non-retinopathy group(P>0.05).Urinary sample:The levels of NAG and isoforms in retionopathy group were higher than non-retinopathy group(P<0.001),and their levels were all higher than the controls(P<0.001).Conclusion NAG and isoforms are the markers at the early stage of retinopathy and nephropathy in children type 1 diabetes mellitus.
出处 《中国实验诊断学》 2007年第11期1456-1458,共3页 Chinese Journal of Laboratory Diagnosis
关键词 1型糖尿病 视网膜病变 N-乙酰-Β-D-氨基葡萄糖苷酶 Type 1 diabetes mellitus retinopathy N-acetyl-beta-D-glucosaminidase
  • 相关文献

参考文献9

  • 1[1]Martin DD,Davis EA,Jones TW.Acute effects of hyperglycaemia in children with type 1 diabetes mellitus:the patient's perspective[J].J Pediatr Endocrinol Metab,2006,19(7):927..
  • 2[2]Danne T,Kordonouri O,Enders I,et al.Monitoring for retionopathy in children and adolescents with type 1 diabetes[J].Acta Paediatr Suppl,1998,425:35.
  • 3[3]Yehong C,Seng Chia K.Markers of dabetic nephropathy.J Diabetes Comp[J],1998,12(1):43.
  • 4[4]Silink M.Global impact of diabetes[J].Pediatr Diabetes,2005;6(suppl3):32.
  • 5[5]Wolf G.New insights into the pathophysiology of diabetic nephropathy:from haemodynamics to molecular pathology[J].Eur J Clin Invest,2004,34:785.
  • 6[6]Schram MT,Chaturvedi N,Schalkwijk C,et al.Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes[J].Diabetes Care,2003,26:2165.
  • 7[7]Tucker SM,Pierce RJ,Price RG.Charac1terisation of human N-scetyl-betaD-glucosaminidase isoenzymes as an indicator of tissue damage in disease[J].Clin Chim Acta,1980 Mar 14,102(1):29.
  • 8[8]Yuuki T,Kanda T,Kimura Y,et al.Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy[J].J Diabetes Complicetions,2001,15:257.
  • 9张楚,童钟杭,夏惕勤.N-乙酰-β-D-氨基葡萄糖苷酶同工酶等电聚焦测定及初步临床应用[J].临床检验杂志,1990,8(2):61-63. 被引量:1

同被引文献30

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部